Gene Therapy Market Set for Transformational Growth, Reaching USD 36.55 Billion by 2032
The global gene therapy market is undergoing a transformative evolution as healthcare systems increasingly shift toward precision medicine and curative therapies. According to recent industry analysis, the gene therapy market is projected to grow from USD 8.85 billion in 2024 to USD 36.55 billion by 2032, registering a robust CAGR of 19.4% during the forecast period. The rising burden of genetic disorders, rare diseases, and cancer, coupled with major advancements in genetic engineering technologies, is accelerating the adoption of gene therapy worldwide. Gene therapy represents one of the most innovative areas in modern medicine. Unlike traditional treatments that primarily manage symptoms, gene therapy focuses on correcting defective genes or modifying cellular functions to address the root cause of diseases. This revolutionary therapeutic approach is gaining strong momentum across neurology, oncology, hematology, and several rare genetic disorders. Download PDF Brochure Risi...